Insulin glargine biosimilar (Getz Pharma)

甘精胰岛素生物类似药 (Getz Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin glargine biosimilar (Getz Pharma)

Drug Alias Name甘精胰岛素生物仿制药 (Getz Pharma)insulin glargine follow-on biologic(Getz Pharma)Basagine

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionInsulin receptor agonists

TargetsInsulin receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGetz Pharma

China Registration ClassN/A

Active CompaniesGetz Pharma

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Inactive IndicationsN/A

ATC CodeA10AE04